Results 271 to 280 of about 5,695,316 (423)

Genetic engineering in the international media: An analysis of opinion-leading magazines [PDF]

, 2000
Matthias Kohring, Alexander Görke
openalex   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source

Recent Advances in Genetic Engineering Strategies of <i>Sinorhizobium meliloti</i>. [PDF]

ACS Synth Biol
Liu X, Dong H, Wang H, Ren X, Yang X, Li T, Fu G, Xia M, Fang H, Du G, Jin Z, Zhang D.   +11 more
europepmc   +1 more source

A CRISPR-dCas Toolbox for Genetic Engineering and Synthetic Biology.

Journal of Molecular Biology, 2019
Xiaoshu Xu, Lei S. Qi
semanticscholar   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

Advancing Natural Killer Cell Therapy: Genetic Engineering Strategies for Enhanced Cancer Immunotherapy. [PDF]

Ann Lab Med
Park JD, Shin HE, An YS, Jang HJ, Park J, Kim SN, Park CG, Park W.   +7 more
europepmc   +1 more source

Ethylene receptors and genetic engineering of ethylene sensitivity in plants.

, 1999
Kumi Sato‐Nara, Ken‐Ichi Yuhashi, Hiroshi Ezura   +2 more
openalex   +2 more sources

469 Multi-faceted Approaches to Genetic Engineering of Petunia × hybrida for Delayed Leaf Senescence [PDF]

, 2000
David G. Clark, Chris Dervinis, Francine Lorena Cuquel, Harry J. Klee, J. T. Barrett, Terril A. Nell   +5 more
openalex   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

Development of a β-glucosidase improved for glucose retroinhibition for cellulosic ethanol production: an integrated bioinformatics and genetic engineering approach. [PDF]

Biotechnol Biofuels Bioprod
Azevedo RDS, Santana H, Seus VR, Camargo AD, Werhli AV, Machado KDS, Cançado LJ, Quirino BF, Marins LF.   +8 more
europepmc   +1 more source